Benefit and Risk of Endomyocardial Biopsy for Heart Transplant Patients in the Contemporary Era.
Vincenzo CusiFlorin VaidaNicholas WetterstenNicholas RodgersYuko TadaBryn GerdingBarry D GreenbergMarcus Anthony UreyEric D AdlerPaul J KimPublished in: medRxiv : the preprint server for health sciences (2023)
The yield of surveillance EMBs has declined in the contemporary era, while for cause EMBs continued to demonstrate a high benefit/risk ratio. The risk of EMB complications was highest within 1 month after HTx. Surveillance EMB protocols in HTx patients may need to be re-evaluated.